Literature DB >> 11000256

Intracellular hepatitis B virus nucleocapsids survive cytotoxic T-lymphocyte-induced apoptosis.

V Pasquetto1, S Wieland, F V Chisari.   

Abstract

Following antigen recognition, hepatitis B virus (HBV)-specific cytotoxic T lymphocytes (CTL) induce a necroinflammatory liver disease in HBV-transgenic mice. An early event in this process is CTL-dependent activation of apoptosis in a small fraction of HBV-positive hepatocytes. Here we show that cytoplasmic HBV nucleocapsids and their cargo of replicative DNA intermediates survive CTL-induced apoptosis of hepatocytes in vitro. These results suggest that destruction of infected cells per se is not sufficient to destroy the replicating HBV genome in infected tissue and that other events in addition to this process are required for viral clearance to occur.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000256      PMCID: PMC112416          DOI: 10.1128/jvi.74.20.9792-9796.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Two regions of an avian hepadnavirus RNA pregenome are required in cis for encapsidation.

Authors:  J Calvert; J Summers
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

2.  Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences.

Authors:  A McLachlan; D R Milich; A K Raney; M G Riggs; J L Hughes; J Sorge; F V Chisari
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

3.  Primary cultures of rat hepatocytes as a model system of canalicular development, biliary secretion, and intrahepatic cholestasis. I. Distribution of filipin-cholesterol complexes during de novo formation of bile canaliculi.

Authors:  R Gebhardt; W Jung; H Robenek
Journal:  Eur J Cell Biol       Date:  1982-11       Impact factor: 4.492

4.  Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites.

Authors:  S Mellouk; N Berbiguier; P Druilhe; M Sedegah; B Galey; L Yuan; M Leef; Y Charoenvit; C Paul; S Hoffman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

5.  Flow cytometric analysis of live cell proliferation and phenotype in populations with low viability.

Authors:  I Schmid; J Ferbas; C H Uittenbogaart; J V Giorgi
Journal:  Cytometry       Date:  1999-01-01

6.  Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice.

Authors:  T Moriyama; S Guilhot; K Klopchin; B Moss; C A Pinkert; R D Palmiter; R L Brinster; O Kanagawa; F V Chisari
Journal:  Science       Date:  1990-04-20       Impact factor: 47.728

7.  Polyclonality and multispecificity of the CTL response to a single viral epitope.

Authors:  T Ishikawa; D Kono; J Chung; P Fowler; A Theofilopoulos; S Kakumu; F V Chisari
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

8.  delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees.

Authors:  M Rizzetto; B Hoyer; M G Canese; J W Shih; R H Purcell; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Proteaselike sequence in hepatitis B virus core antigen is not required for e antigen generation and may not be part of an aspartic acid-type protease.

Authors:  M Nassal; P R Galle; H Schaller
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

10.  Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.

Authors:  K Ando; T Moriyama; L G Guidotti; S Wirth; R D Schreiber; H J Schlicht; S N Huang; F V Chisari
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  7 in total

1.  Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.

Authors:  U Lazdina; T Cao; J Steinbergs; M Alheim; P Pumpens; D L Peterson; D R Milich; G Leroux-Roels; M Sällberg
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 2.  Targeted DNA mutagenesis for the cure of chronic viral infections.

Authors:  Joshua T Schiffer; Martine Aubert; Nicholas D Weber; Esther Mintzer; Daniel Stone; Keith R Jerome
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

3.  Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.

Authors:  Masanori Isogawa; Michael D Robek; Yoshihiro Furuichi; Francis V Chisari
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus.

Authors:  Silke Arzberger; Marianna Hösel; Ulrike Protzer
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

5.  Signal transduction pathways that inhibit hepatitis B virus replication.

Authors:  Michael D Robek; Bryan S Boyd; Stefan F Wieland; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-02       Impact factor: 11.205

6.  Alix regulates egress of hepatitis B virus naked capsid particles in an ESCRT-independent manner.

Authors:  Andreas Bardens; Tatjana Döring; Jens Stieler; Reinhild Prange
Journal:  Cell Microbiol       Date:  2010-12-28       Impact factor: 3.715

Review 7.  Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV.

Authors:  Thomas Vanwolleghem; Tom Adomati; Stijn Van Hees; Harry L A Janssen
Journal:  JHEP Rep       Date:  2021-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.